ZAMBELLO, RENATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.138
EU - Europa 2.501
AS - Asia 1.328
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
AF - Africa 2
Totale 20.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.111
CN - Cina 1.163
DE - Germania 567
IT - Italia 497
FI - Finlandia 463
SE - Svezia 302
UA - Ucraina 261
GB - Regno Unito 214
RU - Federazione Russa 102
VN - Vietnam 66
IN - India 56
IE - Irlanda 40
CA - Canada 24
FR - Francia 22
TR - Turchia 14
JP - Giappone 13
AU - Australia 12
NL - Olanda 8
BE - Belgio 5
EU - Europa 5
ES - Italia 3
HU - Ungheria 3
RS - Serbia 3
TW - Taiwan 3
BG - Bulgaria 2
CH - Svizzera 2
GR - Grecia 2
IR - Iran 2
KW - Kuwait 2
MX - Messico 2
SA - Arabia Saudita 2
SC - Seychelles 2
TH - Thailandia 2
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
HK - Hong Kong 1
ID - Indonesia 1
IL - Israele 1
MK - Macedonia 1
NP - Nepal 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
SG - Singapore 1
Totale 20.991
Salva come PNG Salva come JPEG
Città #
Fairfield 2.740
Ann Arbor 1.659
Woodbridge 1.659
Chandler 1.529
Houston 1.303
Ashburn 1.149
Jacksonville 1.056
Wilmington 1.027
Cambridge 951
Seattle 868
Princeton 482
San Diego 341
Beijing 310
Medford 224
Des Moines 188
Helsinki 180
Nanjing 172
Padova 162
Boardman 144
Guangzhou 139
Roxbury 118
Dong Ket 66
Shenyang 63
Hebei 58
Norwalk 54
New York 52
Changsha 50
Shanghai 50
Nanchang 48
Jiaxing 42
Dublin 39
Jinan 35
London 35
Tianjin 33
Falls Church 31
Redwood City 23
Pune 20
Kharkiv 19
Milan 18
Washington 18
Ningbo 17
Kilburn 14
Chicago 12
Hefei 12
Yenibosna 12
Hounslow 11
Ogden 11
Zhengzhou 11
Borås 10
Ottawa 10
Phoenix 10
Indiana 9
Lanzhou 9
Regensburg 9
Verona 9
Haikou 8
Hangzhou 8
Hanover 8
Rome 8
Orange 7
Rockville 7
Bologna 6
Lappeenranta 6
Las Vegas 6
Nürnberg 6
Portland 6
Prescot 6
Shibuya 6
Tappahannock 6
Florence 5
Fuzhou 5
Kyoto 5
Los Angeles 5
Melbourne 5
Redmond 5
San Francisco 5
Taizhou 5
Amsterdam 4
Bolzano 4
Edinburgh 4
Falkenstein 4
Islington 4
Oderzo 4
Salerno 4
Selvazzano Dentro 4
Treviso 4
Venezia 4
Wandsworth 4
Acton 3
Ahmedabad 3
Auburn Hills 3
Baotou 3
Belgrade 3
Budapest 3
Detroit 3
Forlì 3
Kunming 3
Malo 3
Montreal 3
Pisa 3
Totale 17.535
Salva come PNG Salva come JPEG
Nome #
Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma 168
Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI 164
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation 157
Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction? 150
Identification of a miR-146b-FasL axis in the development of neutropenia in T large granular lymphocyte leukemia 147
Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. 142
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma 142
Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study. 140
Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma 137
Rituximab-responsive CIDP 136
Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia 136
STAT3 mutation impacts biological and clinical features of T-LGL leukemia 134
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 133
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 132
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia 130
Selection of T lymphocyte bearing limited TCR-V beta regions in the lung of hypersensitivity pneumonitis and sarcoidosis. 128
Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. 127
CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis 127
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity 126
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 124
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 123
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 120
Comparative Analysis of NK Receptor and T-Cell Receptor Repertoires in Patients with Chronic Myeloid Leukemia Treated with Different Tyrosine Kinase Inhibitors 117
Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells 117
Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic activity: an enzymatic mechanism for influx of mononuclear phagocytes at site of disease activity 112
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole. 112
Improvement of peripheral nervous system manifestations of B-cell non-Hodgkin's lymphoma after rituximab therapy 111
Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort study 110
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30 109
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation 109
Steroid-responsive hyperammonemic encephalopathy as first manifestation of multiple myeloma 109
IgM MGUS and Waldenstromassociated anti-MAG neuropathies display similar response to rituximab therapy 108
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes 107
Cyclophosphamide as a first-line therapy in LGL leukemia. 107
Lenalidomide long-term neurotoxicity: clinical and neurophysiological prospective study. 107
Immunologic abnormalities in angioimmunoblastic lymphadenopathy. 106
Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy. 106
Long-term effect of rituximab in anti-mag polyneuropathy 105
CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis 105
Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis 105
Lenalidomide for bortezomib- resistant Multiple Myeloma 104
Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia. 103
Psoriasis induced by thalidomide in a patient with multiple myeloma 102
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity 102
Actionable Strategies to Target Multiple Myeloma Plasma Cell Resistance/Resilience to Stress: Insights From “Omics” Research 102
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission. 102
Role of hematopoietic-specific protein 1 (HS1) in apoptosis in B-chronic lymphocytic leukemia. 101
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. 101
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death 101
Antiapoptotic effects of IL-15 on pulmonary Tc1 cells of patients with human immunodeficiency virus infection 100
Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients. 100
T cell large granular lymphocyte leukemia and chronic NK lymphocytosis 100
Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis 99
A Pyrazolo[3,4-d]pyrimidine compound inhibits Fyn phosphorylation and induces apoptosis in natural killer cell leukemia 99
Childhood onset cyclic neutropenia: G-CSF therapy restores neutrophil count but does not influence superoxide anion and cytokine release by neutrophils. 98
Identification of NKp80, a novel triggering molecule expressed by human NK cells 98
The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies. 98
CD8+ T lymphocytes in the lung of AIDS patients harbor Human Immunodeficiency Virus Type 1. 97
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. 97
Role of protein kinase CK2 in the retinoic acid-induced differentiation of acute promyelocytic leukemia cells. 96
State of the art in natural killer cell malignancies. 96
Phenotypical and functional analysis of natural killer cells in sarcoidosis. 95
Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions 95
Cytotoxic Lymphocytes in the Lungs of Patients with Hypersensitivity Pneumonitis 95
Bone marrow stromal cell-fueled multiple myeloma growth and osteoclastogenesis are sustained by protein kinase CK2 95
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and ß-catenin survival signaling pathways 94
The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. 93
Effects of CK2 inhibition on multiple signaling pathways in myeloma cells. 93
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 93
Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy 93
Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients 93
Cellular immunity in sarcoidosis and hypersensitivity pneumonitis: Recent advances. 92
Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders 92
Primary neurolymphomatosis as clinical onset of chronic lymphocytic leukemia 92
Role of GSK3 in multiple myeloma cell growth and survival 91
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes 91
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen. 91
Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL) 90
HIV and pulmonary immune responses. 88
Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes 87
T-cell type lymphoproliferative disease of granular lymphocytes (LDGL) is equipped with a phenotypic pattern typical of effector cytotoxic cells 87
Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes. 86
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission. 86
Rearrangement for T-cell receptor gene and co-expression of immature T-cell markers and natural killer cell phenotype in a patient with acute lymphoblastic leukaemia 86
Intrinsic and Estrinsic Mechanism Contributes to Maintain the JAK/STAT Pathway Aberrantly Activated in T-Type Large Granular Lymphocyte Leukemia 86
CXC chemokines IP-10 and Mig expression and direct migration of pulmonary CD8+/CXCR3+T cells in the lungs of patients with HIV infection and T-cell alveolitis 86
Primary cutaneous mantle cell lymphoma. 85
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response 85
HIV-1 and the lung. Infectivity, pathogenic mechanisms and cellular immune responses taking place in the lower respiratory tract. 84
Studio fenotipico e funzionale dell’attività natural killer in pazienti con sarcoidosi ed alveolite allergica estrinseca. 83
B7 costimulatory molecules from malignant cells in patients with B-cell chronic lymphoproliferative disorders trigger T-cell proliferation 83
Detection of identical T-cell clonotype expansions in both the donor and recipient after allogeneic bone marrow transplantation. 83
A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells 82
Lymphoproliferative disease of granular lymphocytes in a patient with concomitant hepatitis B virus infection of CD4 lymphocytes. 81
Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process 81
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy. 81
Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice 81
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia. 81
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis 81
Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes 80
Totale 10.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.033
article - articoli 71.139
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.693
Totale 149.865
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.257 0 0 0 0 0 0 0 0 0 274 538 445
2019/20204.104 598 108 31 349 386 338 346 462 415 534 296 241
2020/20213.484 205 268 157 187 103 177 335 304 440 371 440 497
2021/20224.095 110 508 469 343 129 257 189 435 187 127 430 911
2022/20233.173 680 324 61 411 483 423 22 190 359 31 136 53
2023/20241.357 77 191 180 131 171 207 108 89 35 168 0 0
Totale 21.259